Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Minqian Shen, MD, PhD

Advertisement

Articles by Minqian Shen, MD, PhD

Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer

BySuneel D. Kamath, MD,Joanna Roopkumar, MD,Ying Ni, PhD,Minqian Shen, MD, PhD,Pablo Bejarano, MD,Daniela Allende, MD,Arun Nagarajan, MD,Tim Nguyen, MD,Bachar Dergham, MD,Dale Shepard, MD, PhD,Marc A. Shapiro, MD,Michael J. McNamara, MD,Bassam N. Estfan, MD,Kanika G. Nair, MD,Alok A. Khorana, MD
December 15th 2023

Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer.

Advertisement

Latest Updated Articles

  • Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer
    Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer

    December 15th 2023



Advertisement
Advertisement

Trending on CancerNetwork

1

BNT113/Pembrolizumab Misses PFS End Point in HPV16+ Head and Neck Cancer

2

RYZ101 Improves Progression-Free Survival in Previously Treated GEP-NETs

3

How Might IMiD Holding Therapy Impact Outcomes in R/R Multiple Myeloma?

4

Teclistamab Vs Talquetamab After Relapse on CAR T-Cell Therapy in Multiple Myeloma

5

How Do Long-Term MAIA and CEPHEUS Data Reinforce Daratumumab Use in NDMM?

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us